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Objective. The Lee-risk index [Lee-index] was developed to predict major adverse cardiac events [MACE]. However, age is
not included as a risk factor. The aim was to assess the value of the Lee-index in vascular surgery patients among different
age categories.
Methods. Of 2 642 patients cardiovascular risk factors were noted to calculate the Lee-index. Patients were divided into
four age categories;  55(n¼ 396), 56e65 (n¼ 650), 66e75 (n¼ 1 058) and >75 years (n¼ 538). Outcome measures
were postoperative MACE (cardiac death, MI, coronary revascularization and heart failure). The performance of the
Lee-index was determined using C-statistics within the four age groups.
Results. The incidence of MACE was 10.9%, for Lee-index 1, 2 and 3; 6%, 13% and 20%, respectively. However, the
prognostic value differed among age groups. The predictive value for MACE was highest among patients under 55 year
(0.76 vs 0.62 of patients aged> 75). The prediction of MACE improved in elderly (aged> 75) after adjusting the Lee-index
with age, revised risk of operation (low, low-intermediate, high-intermediate and high-risk procedures) and hypertension
(0.62 to 0.69).
Conclusion. The prognostic value of the Lee-index is reduced in elderly vascular surgery patients, adjustment with age,
risk of surgical procedure, and hypertension improves the Lee-index significantly.
 2007 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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Peripheral atherosclerotic disease [PAD] is becoming
an increasingly important health issue in the Western
society.1e3 A clear increase of PAD is observed in
elderly subjects. In The Rotterdam Study the preva-
lence of PAD increases from 6.6% in patients aged 55e
59 years to 52% aged>85 years.4 As life expectancy
improves, the prevalence of PAD is on the increase
leading to 16 000 hospital admissions annually in
the Netherlands, 6% of all admissions due to cardio-
vascular diseases.5 Postoperative outcome is related
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E-mail address: d.poldermans@erasmusmc.nl1078–5884/000632 + 07 $32.00/0  2007 Published by Elsevier Ltd oto the presence and extent of coronary artery
disease as well as the regulation of risk factors for
coronary artery disease such as diabetes mellitus,
hyperlipidaemia, and hypertension.1,2,4,6 Commonly,
patients are screened prior to surgery using the Re-
vised Cardiac Risk Index, which includes ischemic
heart disease, heart failure, cerebrovascular disease,
insulin dependent diabetes mellitus, renal dysfunc-
tion, and high-risk surgery.7 However, this risk index
may have a potential limitation for preoperative car-
diac risk assessment in vascular surgery patients as
age is not included and only 21% of the original study
population underwent vascular surgery. In this study
we evaluated the prognostic value of the Revised
Cardiac Risk Index and determined if the accuracy
could be improved by the addition of different age
categories and additional risk factors.n behalf of European Society for Vascular Surgery.
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Study design and patient selection
Between January 1993 and June 2006, 2 730 open non-
cardiac vascular surgical procedures were performed
in patients above 18 years old at Erasmus MC, Rotter-
dam, the Netherlands. Patients were divided into four
categories according to their age: 55, 56e65, 66e75
and>75 years respectively. We excluded 88 procedures
that were conducted within 30 days after the index pro-
cedure. The postoperative outcome of the remaining
2 642 procedures, performed in 2 298 different patients,
was analyzed. Over the 13-year observation study, 250
patients had multiple surgical procedures. The proce-
dure and not the patient was the unit of analysis
because this approach is consistent with clinical prac-
tice, wherein the risk of perioperative complications is
assessed in relation to a specific procedure. The Medi-
cal Ethics Committee of the Erasmus MC was informed
about the study protocol, and per institutional practice
no official approval was requested.
Revised Cardiac Risk Index factors
The Revised Cardiac Risk Index [Lee-index] assigns
1 point to each of the following 6 characteristics: high-
risk surgery, ischemic heart disease, history of heart
failure, cerebrovascular disease, renal insufficiency
and insulin dependent diabetes mellitus. Ischemic
heart disease was defined as a history of MI or positive
stress test, current complaint of ischemic chest pain, or
use of nitrate therapy, or Q waves on the electrocardio-
gram, but patients with a history of coronary artery by-
pass grafting [CABG] or percutaneous coronary
intervention [PCI] were included only if they had cur-
rent complaints of chest pain presumed to be due to is-
chemia; heart failure was defined as a history of heart
failure, pulmonary edema, or paroxysmal nocturnal
dyspnea, or a chest radiograph showing pulmonary
vascular redistribution; renal insufficiency was a creat-
inine level> 177 umol/L; high-risk surgery as AAA,
r-AAA and LLR procedures; and cerebrovascular dis-
ease was defined as a history of a stroke or transient
ischemic attack. Notably, due to the high surgical risk
of LLR, AAA and r-AAA surgery, by definition no
Lee-index of 0 points was reported in these patients.
This resulted in three categories according to the num-
ber of Lee risk index points: 1, 2 and 3.
Other risk factors
Other baseline risk factors recorded of all patients
were age, gender, hypertension (defined as systolicblood pressure 140 mmHg, diastolic blood pressure
 90 mmHg and/or use of anti-hypertensive medica-
tion), chronic obstructive pulmonary disease [COPD]
according to symptoms and pulmonary function tests
(i.e. forced expiratory volume in 1 second <70% of
maximal age and gender predictive value), body
mass index, smoking status, hypercholesterolemia
(total cholesterol of >5.2 mmol/L) and medication
(including statins, diuretics, angiotensin-converting-
enzyme inhibitors, calcium antagonists, nitrates,
beta-blockers, aspirin and anti-coagulants). All pre-
scription and over-the-counter medications were
noted on the day of admission.
Procedures
All patients underwent open vascular surgery, respec-
tively: carotid endarterectomy [CEA], elective infrare-
nal abdominal aortic surgery [AAA], acute infrarenal
AAA surgery [r-AAA] and lower limb arterial recon-
struction procedures [LLR].
Clinical follow-up and end points
Perioperative clinical information was retrieved from
an electronic database of patients maintained in our
hospital. From the municipal civil registries, we ob-
tained the survival status. The follow-up was com-
plete in 98.2%. The primary outcomes were major
adverse cardiac event [MACE] and all-cause mortal-
ity, occurring within 30 days after surgery. The sec-
ondary outcome was all-cause mortality during
long-term follow-up. MACE within 30-days after sur-
gery, was defined as cardiac death (which was defined
as any death with a cardiac complication as the pri-
mary or secondary cause, including deaths following
myocardial infarction, cardiac arrhythmia and heart
failure), myocardial infarction or coronary revascular-
ization (PCI or CABG). Sudden death in a previously
stable patient was considered as cardiac death. Myo-
cardial infarction was defined as the presence of 2
out of the following 3 criteria: (1) typical chest-pain
complaints, (2) electrocardiographic changes includ-
ing acute ST elevation followed by appearance of Q
waves or loss of R waves, or new left bundle branch
block, or new persistent T wave inversion for at
least 24 hours, or new ST segment depression which
persists >24 hours, and (3) a positive troponin T, ie
>0.10 ng/ml (>0.1 ug/L), or peak creatinine phos-
phokinase -MB >8% of an elevated total creatinine
phosphokinase with characteristic rise and fall. Heart
failure was defined according the New York Heart As-
sociation classification. In addition, the causes of deathEur J Vasc Endovasc Surg Vol 34, December 2007
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into three different categories: (1) cerebro-cardiovascular
death [CCVD], (2) non-cerebrocardiovascular death
[non-CCVD] and (3) unknown cause of death.
Cerebro-cardiovascular death was defined as any
death with a cerebro-cardiovascular complication
as the primary or secondary cause and included
deaths following myocardial infarction (MI), serious
cardiac arrhythmias (defined as the presence of a
sustained cardiac rhythm disturbance that required
urgent medical intervention), congestive heart failure,
stroke [cerebro vascular accident (CVA) or transient
ischemic attack (TIA)], surgery-related fatal bleeding
complications and others. Non-CCVD was defined
as any death with a principal non-cerebro-cardiovas-
cular cause, including infection, malignancy, respira-
tory insufficiency and others. The cause of death
was ascertained by reviewing medical records, the
computerized hospital database, autopsy reports, or
by contacting the referring physician or general
practitioner.
Statistical analysis
Continuous data are described as mean values and
its standard deviation [ SD], and dichotomous data
are described as percentage frequencies. The chi-
square test was used for categorical variables
and the analysis of variance [ANOVA] was used
for continuous variables. Univariable logistic regres-
sion analysis was used to evaluate the relation
between the Lee-index and MACE for each age cate-
gory. Multivariable logistic analysis was performed
to evaluate whether the predictive power of the Lee-
index could be improved by adding age, hyperten-
sion and more detailed information on the type of
surgery (low risk (CEA), low-intermediate risk
(LLR), high-intermediate risk (AAA) and high risk
(r-AAA)). The performance of the risk model was
determined by the C-statistics and its resulting area
under the receiver operating characteristics [ROC]
curve [AUC], which indicates how well a model
rank orders patients with respect to their outcome
(where 0.5 indicates no predictive value and 1.0 indi-
cates perfect performance). Kaplan-Meier survival
analysis was used to compare survival of patients,
according to the three Lee-index categories. To test
for differences between the resulting curves, the
log-rank test was used. A p value of <0.05 was con-
sidered to be significant. All computations were per-
formed with SPSS software version 12.0.1 (SPSS Inc.,
Chicago, Illinois, USA), running under Windows
2000 Professional.Eur J Vasc Endovasc Surg Vol 34, December 2007Results
Patient characteristics
A total of 2 642 procedures were performed (21%
CEA, 8% r-AAA, 34% AAA and 38% LLR). The
mean age was 66 11 years and 75% of the patients
were men. Of these patients, 396 (15%) were 55,
650 (25%) were 56e65, 1 058 (40%) were 66e75 and
538 (20%) were > 75 years. Men were 0.97 years older
than were female ( p 0.052). With increase of age,
higher incidences of hypertension, COPD, ischemic
heart disease and r-AAA and AAA surgery were
observed (Table 1). No patients were reported with
a Lee-index score of 0, as all patients with CEA had
a positive history of cerebrovascular disease and/or
presence of another risk factor used in the Lee risk in-
dex. The majority of patients had a score of 1 point
(52%), followed by 30% and 18%, respectively 2 and
3 points (Table 2).
Primary end-point
A total of 287 (10.9%) patients had a major adverse
cardiac event, for Lee-index 1, 2 and 3 respectively
6.2%, 13.2% and 20.5%. Increasing rates of MACE
were found with increased age, with a slight drop of
incidences within patients aged >75 years. Within
each age category, the Lee-index was significantly as-
sociated with incidences of MACE. A correlation of
all-cause mortality and Lee-index was found in all pa-
tients (p 0.03). However, no correlation of the Lee-
index and all-cause mortality was found within each
age category. Cerebro-cardiovascular events (116
(76%)) were the major cause of death which included:
MI 19%, heart failure 10%, cardiac arrhythmia 10%,
stroke 6%, fatal bleeding 26% and others 5%. The
non-cerebro-cardiovascular (36 (24%)) events in-
cluded: infection 14%, malignancy 0%, respiratory
insufficient 6% and others 4%. None patients had an
unknown cause of death. In total, 58 (39%) patients
died because of cardiac complications within 30 days
after surgery.
In univariate analysis, the Lee-index was associated
with an increased risk of MACE as its individual com-
ponents (Table 3). The prospective C-statistic for the
prediction of MACE was 0.65. The predictive value
of the Lee-index was significantly superior in patients
aged55 years compared to patients aged>75 years
(area under the curve 0.76 vs. 0.62, p< 0.01). When
more detailed information, including type of surgery
(low, low-intermediate, high-intermediate and high
risk of surgery), age (55, age 56e65, age 66e75 and
635Cardiac Risk Prediction in Vascular SurgeryTable 1. Baseline characteristics of all patients undergoing major vascular surgery, grouped into four age categories
All [2 642
(100%)]
Age 55
[396 (15%)]
Age 56e65
[650 (25%)]
Age 66e75
[1 058 (40%)]
Age> 75
[538 (20%)]
P value
Demographics
Mean age ( SD) 66 ( 11) 47 ( 8) 61 ( 3) 70 ( 3) 79 ( 4) <0.001
Male (%) 75 68 79 77 74 <0.001
Revised Cardiac Risk Index factors (%)
Ischemic heart disease 30 25 31 29 32 0.05
Heart failure 5 6 5 5 7 0.5
High-risk surgery 79 79 77 77 87 <0.001
Abdominal aortic surgery 34 30 32 36 36 0.06
Acute aortic surgery 8 3 5 9 13 <0.001
Lower limb reconstruction 37 47 40 32 39 <0.001
Renal insufficiency 6 7 5 6 5 0.4
Insulin dependent
diabetes mellitus
15 17 12 14 17 0.08
Cerebrovascular disease 31 27 34 34 25 <0.001
Other risk factors (%)
COPDa 18 11 15 21 23 <0.001
Current smoker 24 25 27 23 22 0.2
Hypercholesterolemia 18 25 19 16 13 <0.001
Body mass index ( SD) 25.1 ( 5) 25.4 ( 5) 25.3 ( 6) 24.9 ( 4) 24.7 ( 3) 0.02
Hypertension 46 39 44 47 48 0.02
Medication use:
Statins 26 31 31 26 16 <0.001
Diuretics 18 13 15 19 23 <0.001
ACE-inhibitorsb 31 28 34 31 33 0.2
Calcium antagonists 34 33 33 35 31 0.4
Nitrates 19 15 19 19 21 0.2
Beta-blockers 33 31 35 35 31 0.3
Aspirin 40 37 40 42 40 0.3
Anti-coagulation 20 18 22 20 18 0.4
a COPD¼ chronic obstructive pulmonary disease.
b ACE-inhibitors¼ angiotensin-converting-enzyme inhibitors.>75 years) and history of hypertension, was added to
the model, the overall C-statistics improved to 0.71. Im-
portantly, after the introduction of these additional risk
factors no difference in the C-statistics was observed
between each age category 55, age 56e65, age
66e75 and >75 years), respectively 0.71, 0.71, 0.69
and 0.69. The prediction of MACE in elderly patients
improved from 0.62 to 0.69 (p¼ 0.02).
Important differences in incidence of MACE were
observed in relation to type of surgery. Overall
incidences of MACE according to low-risk (CEA),
low-intermediate (LLR), high-intermediate (AAA)
and high-risk (r-AAA) surgery were 2.4%, 11.6%,
12.3% and 24.0%, respectively (p< 0.001) (Fig. 1).
Within each type of surgery, the Lee-index was signif-
icantly associated with risk of MACE.
When we perform our analysis applied only
to patients having a single procedure (n¼ 2 298,
66 11 years, 75% were men), our results remained
the same. For example, incidences of hypertension
were 38%, 43%, 46% and 47% for age category 55,
56e65, 66e75 and> 75 years respectively (p 0.03).
The prospective C-statistic for the prediction of MACE
was also 0.65 (0.76, 0.66, 0.64 and 0.62 for each agecategory (55, age 56e65, age 66e75 and> 75 years)).
After the introduction of our additional risk factors no
difference in the C-statistics was observed between
each age category, respectively 0.74, 0.73, 0.71 and
0.71. The multivariate analysis showed the same
results as presented in Table 3. Because of these find-
ings, we concluded that the influence of patients with
multiple procedures on the overall results does not
have an important impact on our results.
Secondary end-point
Although the Lee-index was originally developed to
predict perioperative cardiac complications, a clear
association was found between the Lee-index and
all-cause mortality during follow-up (Fig. 2). A total
of 1 454 (55%) patients died during mean period of
6.4 3.9 years. Annual mortality rates of patients
with a Lee-index score of 1, 2 and 3 were 5.2%/year,
6.4%/year and 7.3%/year respectively (p< 0.001). In
multivariate analysis, adjusting for the four age
categories, risk of surgery (low, low-intermediate,
high-intermediate and high risk), year of operation,Eur J Vasc Endovasc Surg Vol 34, December 2007
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All Lee-index 1 Lee-index 2 Lee-index 3 P value Area under
the curve
Area under
the curveb
All
Incidences n (%) 2 642 (100) 1 371 (52) 802 (30) 469 (18)
All-cause death n (%) 152 (5.8) 63 (4.6) 55 (6.9) 34 (7.2) 0.03
MACE n (%) 287 (10.9) 85 (6.2) 106 (13.2) 96 (20.5) <0.001 0.65 0.71
Age 55
Incidences n (%) 396 (100) 234 (59) 94 (24) 68 (17)
All-cause death n (%) 10 (2.5) 5 (2.1) 3 (3.2) 2 (2.9) 0.84
MACE n (%) 17 (4.3) 3 (1.3) 5 (5.3) 9 (13.2) <0.001 0.76 0.71
Age 56e65
Incidences n (%) 650 (100) 346 (53) 200 (31) 104 (16)
All-cause death n (%) 22 (3.4) 10 (2.9) 7 (3.5) 5 (4.8) 0.63
MACE n (%) 60 (9.2) 21 (6.1) 17 (8.5) 22 (21.2) <0.001 0.64 0.71
Age 66e75
Incidences n (%) 1 058 (100) 543 (51) 335 (32) 180 (17)
All-cause death n (%) 68 (6.4) 30 (5.5) 23 (6.9) 15 (8.3) 0.38
MACE n (%) 144 (13.6) 43 (7.9) 59 (17.3) 43 (23.9) <0.001 0.64 0.69
Age> 75
Incidences n (%) 538 (100) 248 (46) 173 (32) 117 (22)
All-cause death n (%) 52 (9.7) 18 (7.3) 22 (12.7) 12 (10.3) 0.17
MACE n (%) 66 (12.3) 18 (7.3) 26 (15.0) 22 (18.8) 0.003 0.62 0.69
MACE¼major adverse cardiac event.
a Index that assigns one point to each of the following characteristics: ischemic heart disease, history of heart failure, high-risk surgery,
history of cerebrovascular disease, renal insufficiency and diabetes mellitus.
b Adjusted for type of surgery (low, low-intermediate, high-intermediate and high risk of surgery), age ( 55, 56e65, 66e75 and
>75 years) and history of hypertension.chronic obstructive pulmonary dysfunction, hyper-
cholesterolemia, smoking status, body mass index,
gender, hypertension and cardiovascular medication,
the risk of all-cause mortality was 1.45 (95% CI:
Table 3. Unadjusted and adjusted predictors of estimate risk of
major adverse cardiac events
Unadjusted HR,
(95% CI)
Adjusted HRa,
(95% CI)
Lee-index 1 (reference) 1.0 1.0
Lee-index 2 2.30 (1.71e3.11) 1.94 (1.37e2.73)
Lee-index 3 3.89 (2.85e5.33) 2.92 (1.92e4.44)
High-risk surgery 6.17 (3.51e10.85) 6.97 (3.68e13.22)
Diabetes mellitus 1.84 (1.36e2.48) 1.51 (1.11e2.06)
Cerebrovascular disease 1.76 (1.26e2.45) 1.53 (1.09e2.14)
Ischemic heart disease 2.31 (1.80e2.97) 1.70 (1.30e2.22)
Heart failure 2.43 (1.60e3.68) 1.31 (0.84e2.06)
Renal insufficiency 2.24 (1.64e3.05) 1.71 (1.24e2.36)
Age 55 years (reference) 1.0 1.0
Age 56e65 years 2.27 (1.30e3.94) 2.44 (1.34e4.42)
Age 66e75 years 3.51 (2.10e5.89) 3.49 (1.99e6.10)
Age> 75 years 3.11 (1.80e5.40) 2.56 (1.41e4.65)
Low-risk surgery (reference) 1.0 1.0
Low-intermediate risk 5.36 (2.99e9.60) 4.04 (2.17e7.54)
High-intermediate risk 5.76 (3.21e10.34) 4.14 (2.23e7.68)
High-risk 12.95 (6.84e24.52) 10.45 (5.22e20.95)
History of hypertension 2.15 (1.67e2.77) 1.70 (1.25e2.31)
HR¼ hazard ration; CI¼ confidence interval.
a Adjusted for the the four age categories ( 55, 56e65, 66e75 and
>75 years), risk of surgery (low, low-intermediate, high-intermediate
and high risk), hypertension, year of operation, chronic obstructive
pulmonary dysfunction, hypercholesterolemia, smoking status,
body mass index, gender and cardiovascular medication.Eur J Vasc Endovasc Surg Vol 34, December 20071.28e1.65) for Lee-index 2 and 1.90 (95% CI: 1.63e
2.22) for Lee-index 3, compared with Lee-index 1.
When analysis was performed to patients with a single
procedure, the risk of all-cause mortality was 2.01
(95% CI: 1.37e2.94) for Lee-index 2 and 3.11 (95%
CI: 1.94e4.97) for Lee-index 3, compared with
Lee-index 1.
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Fig. 1. Incidences of major cardiac events, according to type
of operation and the Revised Cardiac Risk score. MACE¼
major adverse cardiac events; r-AAA¼ acute infrarenal
AAA surgery; AAA¼ elective infrarenal abdominal aortic
surgery; LLR¼ lower limb arterial reconstruction
procedures; CEA¼ carotid endarterectomy, *Lee-index that
assigns one point to each of the following characteristics:
ischemic heart disease, history of heart failure, high-risk sur-
gery, history of cerebrovascular disease, renal insufficiency
and diabetes mellitus.
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The main finding of our study is that the prognostic
value of the Revised Cardiac Risk Index [Lee-index]
is reduced in the very elderly patients (>75 years) un-
dergoing vascular surgery. The Lee-index was intro-
duced to assess perioperative cardiac risk among
a large number of patients. Risk factors included are
high-risk surgery, ischemic heart disease, history of
heart failure, cerebrovascular disease, renal insuffi-
ciency and insulin dependent diabetes mellitus. Im-
portantly, age was not included in the index. In
addition, only a low number of vascular surgery pa-
tients were included. Our study showed that if addi-
tional information was added to the Lee-index (e.g.
age, a more detailed classification of type of vascular
surgery and history of hypertension), the accuracy
of the Lee-index to predict postoperative MACE im-
proves significantly in vascular surgery patients,
among the entire strata of age.
The Lee-index is a modification of the original
Goldman risk index,8 developed in the 1990s and val-
idated in numerous clinical studies and is currently
considered the best available risk model. Although
the Lee-index was developed using clinical data of
4 315 consecutive patients undergoing non-cardiac
surgery, the model has shortcomings for vascular
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Fig. 2. All cause long-term mortality in 2 642 patients who
underwent major vascular surgery, according to the Revised
Cardiac Risk score. Lee-index that assigns one point to each
of the following characteristics: ischemic heart disease,
history of heart failure, high-risk surgery, history of cerebro-
vascular disease, renal insufficiency and diabetes mellitus.surgery patients. Of all patients, only 21% underwent
vascular surgery and all procedures were considered
as high-risk. However, postoperative morbidity and
mortality varied considerably among different vascu-
lar surgical procedures.9e11 In order to improve the
predictive value of the Lee-index, we specified the
type of vascular surgery into four categories; low,
low-intermediate, high-intermediate and high-risk.
However, the main limitation of the Lee-index is
that age is not included. The number of patients re-
ferred for vascular surgery is increasing with a sub-
stantial number of septo- and octogenarians. The
average age of AAA surgery increased from 69 to
72 years during 1980e2000.12 In addition, this aging
population presents with complex co-morbidity asso-
ciated with increased postoperative mortality rates.
Several risk indices have been developed to stratify
vascular surgery patients based on age and clinical car-
diac risk factors. In 1994, Samy et al. developed a scoring
system in 500 patients scheduled for abdominal aortic
aneurysm surgery for the prediction of postoperative
mortality; the Glasgow aneurysm score.13 This score in-
cluded myocardial disease, cerebrovascular disease, re-
nal dysfunction and age as a continuous variable as
risk factors. Age was an independent risk factor for post-
operative mortality (p¼ 0.02). Steyerberg et al. con-
structed the Leiden Risk Model in 246 patients
undergoing abdominal aortic aneurysm surgery and in-
cluded age per decade (<60, 60e70 and>70 years) as
a risk factor.14 Age had only a moderate predictive value
for all-cause perioperative mortality (OR 1.9; 95% CI:
0.9e4.2). In addition, L’Italien et al. developed a risk
model among 1 081 patients undergoing different vascu-
lar surgical procedures, with an overall predictive value
for cardiac death and non-fatal myocardial infarction
of 0.74 (C-statistic).15 They included advanced age
(>70 years) as a dichotomous risk factor. The limitations
of these studies are the low number of patients included,
none of the studies had MACE as their end-point and the
focus is predominantly on aortic surgery.
Preoperative cardiovascular risk stratification has
been an area of intense interest for identifying
patients at higher cardiac risk. Patients classified as
high risk can be refrained for surgery or should be
considered to undergo less invasive surgery (like en-
dovascular procedures). Additional cardio protective
therapy in elderly (like beta-blockers and statins16e18)
in reduction of perioperative cardiac complications
has improved in recent years. In addition to the im-
mediate postoperative outcome, prognostic indices
should be considered to assess long-term prognosis,
as patients should live long enough to enjoy the
benefits of surgery. As shown in the follow-up of
patients undergoing major vascular surgery withEur J Vasc Endovasc Surg Vol 34, December 2007
638 G. M. J. M. Welten et al.different cardiac risk index scores, annual mortality
rates increased by each risk factor added, ranging
from 5.2%/year in patients with 1 risk factor, to
6.4%/year and 7.3%/year for 2 and 3 risk factors
respectively. This indicates that the prognosis is
related to underlying cardiovascular disease. Post-
operative surveillance of patients among the high-
risk scores with aggressive anti-ischemic therapy is
indicated to improve long-term outcome.
A major limitation of our study is the retrospective
analysis of prospectively collected data. Changes in
the perioperative management have evolved mark-
edly over time and were not taken into account in
our analysis. These include multiple factors ranging
from preoperative management, such as drug therapy,
anesthesiological and surgical techniques to intensive
post-surgical care management. We tried to adjust for
this confounding to add the year of operation in our
multivariate analysis, resulting in Table 3.
In conclusion: this revision of the Lee-index, now
including age, risk of surgery and hypertension,
clearly stratifies vascular surgery patients into low,
intermediate and high risk. In addition, this model
provides long-term prognostic value.
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